Welcome to this week’s edition of 18 Share Tips: our weekly selection of top ASX shares, chosen by leading analysts, that we think are worth considering.
This week John Athanasiou of Red Leaf Securities, Angus Geddes of Fat Prophets, and Andrew Wielandt of DP Wealth Advisory share their ‘Buy’, ‘Hold’ and ‘Sell’ recommendations.
Please note these share tips are simply recommendations and are in no way intended as financial advice. These share tips are general advice and don’t take into account any individual’s financial situation. Investors are advised to seek professional financial advice before investing.
John Athanasiou, Red Leaf Securities
BUY RECOMMENDATIONS
BUY – TechnologyOne (TNE)
This technology company holds an embedded position in enterprise resource planning software across government, education and the corporate sector. The business benefits from long duration contracts, expensive switching costs and a highly recurring revenue base underpinning strong earnings visibility. The company has consistently delivered double-digit earnings growth, while maintaining disciplined cost control. While the valuation remains elevated, it’s broadly supported by earnings visibility and structural digitisation tailwinds. In a market favouring predictable cashflows and defensiveness, TechnologyOne remains a core long duration compounder.
BUY – Regis Resources (RRL)
Unaudited gold production of 101,500 ounces in the June quarter of 2026 was up 12 per cent on the prior quarter. Group gold production guidance for full year 2026 is at the top end of guidance at 379,000 ounces. The company had $1.21 billion in cash and bullion on hand at June 30, 2026, an increase of $692 million over the full financial year. Earnings remain highly sensitive to gold price movements. However, improving cash generation and a stronger balance sheet provide support through the cycle. Regis remains a clean, leveraged expression to the gold theme.
HOLD RECOMMENDATIONS
HOLD – Evolution Mining (EVN)
EVN is a gold mining company with additional exposure to copper. Cash flow generation strengthened materially in the elevated gold price environment, supporting improved financial flexibility. This has underpinned the stock’s re-rating alongside the broader sector. Much of the gold price outlook is now reflected in the valuation, limiting incremental upside unless bullion prices accelerate further. In our view, EVN is increasingly a defensive gold proxy rather than a high growth vehicle.
HOLD – Pro Medicus (PME)
Pro Medicus remains a premium healthcare technology compounder with a dominant position in US medical imaging software. The company exhibits strong operating leverage, minimal churn and structurally high returns on capital. However, valuation is the binding constraint. The market already embeds sustained high growth over an extended horizon, reducing the margin of safety. PME remains a high quality hold, with upside dependent on continuing US market expansion and incremental large scale contract wins.
SELL RECOMMENDATIONS
SELL – PLS Group (PLS)
PLS is a leading Australian lithium producer. Lithium remains structurally linked to electrification, but near term fundamentals are challenged by expanding supplies. While PLS asset quality remains strong, earnings are highly leveraged to spot prices, generating volatility through the cycle. Balance sheet strength provides a buffer, but doesn’t offset cyclical earnings pressure. PLS remains a high risk recovery trade dependent on the timing of lithium re-balancing, with limited near term visibility.
SELL – Mineral Resources (MIN)
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - market-leading social trading platform - Read our review
MIN is a diversified resources company, with extensive operations in lithium, iron ore, energy and mining services across Western Australia. The diversified model provides some cash flow stability via mining services, but overall earnings remain cyclical and exposed to volatile bulk commodity markets. Higher leverage amplifies downside risk during commodity downturns. Execution complexity across multiple divisions adds additional risk relative to simpler, more focused producers. While the company retains strategic asset value, earnings stability remains inconsistent, in our view. Until we see a reduction in leverage and earnings volatility, the stock remains a sell, or in the underweight category.
Angus Geddes, Fat Prophets
BUY RECOMMENDATIONS
BUY – James Hardie Industries PLC (JHX)
This building products company is the biggest supplier of exterior cladding to the US production home building market, with fibre cement underpinning demand. United States company giant Berkshire Hathaway’s acquisition of home builder Taylor Morrison Home Corporation is a calculated bet on the structural housing deficit and a vote of confidence for the broader housing related group. EBITDA beat guidance in fiscal year 2026, with synergies ahead of schedule. The stock looks undervalued when looking through the cycle.
BUY – Collins Foods (CKF)
The fast food restaurant owner operates franchised KFC networks across Australia and Europe. Group record revenue of $A1.592 billion in fiscal year 2026 was up 8.6 per cent on the prior corresponding period. Underlying net profit after tax of $A61.4 million grew 13 per cent. Same store sales in Australia were up 2.7 per cent. KFC Europe returned to positive same store sales growth driven by a 3.7 per cent recovery in Germany. The exit from Taco Bell enables more capital allocation to the KFC brand in Australia and Europe. Total KFC sales in Australia grew by 6.7 per cent in the first eight weeks of fiscal year 2027. The stock appears poised to move higher.
HOLD RECOMMENDATIONS
HOLD – Evolution Mining (EVN)
Evolution is a diversified gold and copper producer giving it a structural edge over gold only peers. A fortress balance sheet and a 31 million ounce gold resource underpin quality and we expect margins will remain wide despite a pull-back in the gold price during 2026. The company has a suite of quality assets and operational execution has been impressive. Our hold recommendation reflects a softer gold backdrop as opposed to issues with business operations
HOLD – CSL (CSL)
CSL remains a leading global plasma and biotechnology company. CSL Behring remains a key earnings engine. A series of setbacks has tested investor trust. Multiple guidance cuts, about $US5 billion of largely non-cash CSL Vifor impairments, postponed the spin off of influenza vaccine subsidiary Seqirus amid senior leadership changes. The shares have rebounded off multi-year lows of less than $100, but remain well below previous highs. The core business quality appears intact and the valuation is undemanding, but sentiment remains fragile.
SELL RECOMMENDATIONS
SELL – Worley (WOR)
Worley provides engineering and project services across energy, chemicals and resources. A fresh fiscal year profit warning for full year 2026 in response to the Middle East conflict is testing investor trust in Worley. The company expects the impact to underlying EBITA of up to $60 million, an increase from the previous estimate of $30 million to $40 million. Also, a foreign currency translation impact, estimated to be $50 million in full year 2026, is a result of a stronger Australian dollar in the second half. The company has been experiencing project delays in the Middle East. In our view, Worley’s undemanding valuation is providing little support without visible earnings upgrades.
SELL – Bapcor (BAP)
Bapcor is an aftermarket automotive parts provider in Australia and New Zealand. It operates the Autobarn, Burson and Autopro brands. A collapse in underlying net profit after tax in the first half of 2026 and a dilutive $200 million equity raising have reset Bapcor’s earnings and capital structure. Underlying EBITDA in the first half of 2026 fell about 40 per cent on the prior corresponding period. The significantly discounted equity raise leaves the share count close to double its prior level. In May, the company downgraded full year underlying EBITDA guidance to between $144 million and $150 million.
Andrew Wielandt, DP Wealth Advisory
BUY RECOMMENDATIONS
BUY – L1 Long Short Fund (LSF)
LSF provides exposure to long and short strategies on a global scale, meaning it takes either a positive or negative view on each position in the portfolio. The strategy holds between 50 and 100 companies, with 30 per cent or less held offshore. The fund has delivered returns of 20.2 per cent per annum since its inception in 2014. LSF has risen from $2.97 on July 10, 2025 to trade at $4.66 on July 9, 2026. The fund has a strong track record of delivering results and I believe the outlook is bright. I hold LSF in my self managed super fund.
BUY – Plato Global Alpha Fund Complex ETF (PGA1)
The fund’s objective is to outperform the MSCI world net returns unhedged index by 4 per cent per annum over the medium to long term. The fund focuses on value, growth and quality factors and is well managed. In the past three years, the fund’s net performance is up 32.6 per cent per annum to May 31, 2026. It holds numerous long and short positions. We expect favourable momentum to continue. The fund has risen from$11.91 on July 14, 2025 to trade at $15.01 on July 9, 2026. I hold PGA1 in my self managed superannuation fund.
HOLD RECOMMENDATIONS
HOLD – Woolworths Group (WOW)
The supermarket giant generates a strong return on equity, but profits are tighter. The company generated group sales of $18.1 billion in the third quarter of fiscal year 2026, up 4.5 per cent on the prior corresponding period. Guidance for reported full year 2026 Australian food earnings before interest and tax growth is expected to be in the mid to high single digit range, but no longer at the upper end of the range. Defensive earnings from supermarkets should underpin its business despite the weakening Australian economy.
HOLD – Wesfarmers (WES)
WES is one of Australia’s largest diversified industrial companies, spanning retail, chemicals, fertilisers, industrials and health. The retail division, including hardware giant Bunnings, Kmart Group and Officeworks, continues to perform well despite a slowing domestic economy. Investment in the Priceline pharmacy chain provides upside potential. WES generates a strong return on shareholders funds, but the stock is trading near a 12-month broker consensus target price, so we retain a hold recommendation.
SELL RECOMMENDATIONS
SELL – Worley (WOR)
Worley provides engineering and project services across energy, chemicals and resources. The Middle East conflict is causing disruption in progressing existing projects, which is forecast to have an adverse impact on earnings in full year 2026. A stronger Australian dollar is also forecast to impact results. An uncertain outlook in the Middle East paints a softer outlook moving forward.
SELL – REA Group (REA)
REA is the dominant online property platform in Australia. But competitor Domain Holdings Australia, acquired by US listed company CoStar Group, is expected to provide fierce competition. Federal Budget changes to capital gains tax and negative gearing leaves property far less appealing to investors. The Australian property market is slowing, which could impact REA listing volumes moving forward. Auction clearance rates have been falling in Sydney and Melbourne. Other stocks appeal more at this stage of the cycle.
The above recommendations are general advice and don’t take into account any individual’s objectives, financial situation or needs. Investors are advised to seek their own professional advice before investing. Please note that TheBull.com.au simply publishes broker recommendations on this page. The publication of these recommendations does not in any way constitute a recommendation on the part of TheBull.com.au. You should seek professional advice before making any investment decisions.
